The pharmaceutical industry relies heavily on a consistent supply of high-quality intermediates to produce essential medicines. Erythromycin Estolate (CAS 3521-62-8) is a prime example of such a critical compound, serving as a potent antibiotic and a valuable intermediate in drug synthesis. Understanding its specifications and how to procure it efficiently is key for professionals in the field.

Erythromycin Estolate is primarily recognized for its therapeutic use as an antibiotic. It is particularly effective against infections caused by Staphylococcus aureus, including strains resistant to penicillin. This makes it a crucial alternative for patients who are allergic to penicillin or for whom other treatments have proven ineffective. Its broad-spectrum activity and favorable absorption profile make it a staple in treating various bacterial infections.

For pharmaceutical companies and formulators, the quality of Erythromycin Estolate is paramount. This means adhering to strict quality standards such as USP, BP, EP, and FCC, with a guaranteed assay of at least 99.0%. These certifications assure that the intermediate is pure, safe, and will perform as expected in the final drug product. Manufacturers who invest in robust quality management systems, often validated by certifications like GMP and SGS, are essential partners.

As a leading manufacturer of Erythromycin Estolate in China, we are dedicated to meeting these global quality demands. We offer a reliable supply of this essential antibiotic intermediate, ensuring that our clients can purchase it with confidence. Our production capabilities are designed for efficiency, allowing us to offer competitive pricing. Standard packaging of 25kg/drum and a minimum order of 500kg are available to suit various industrial needs. We encourage you to contact us for price inquiries and to explore how we can fulfill your requirements for Erythromycin Estolate.

Partnering with a reputable Chinese manufacturer for Erythromycin Estolate ensures not only high-quality products but also a stable and cost-effective supply chain. This strategic sourcing is vital for maintaining production schedules and ultimately delivering critical antibiotic treatments to patients worldwide.